Shilpa Medicare Limited has entered into a binding agreement with NXI Therapeutics AG Based out of Basel Switzerland for development supply of a New Chemical Entity (NCE)
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]